Considering the importance of SOCS2 in Tregs in their noteworthy suppressive potential of the differentiation and function of CD4+ T cells and tumor-killing CD8+ T cells in the TME, the roles of m6A methylation of SOCS2 mRNA in T cells in immune response disorders during tumorigenesis should be further explored. The gene discussed is CD8A; the disease is neoplasm.